Vontobel Holding
XFOR icon

Vontobel Holding’s X4 Pharmaceuticals XFOR Stock Holding History

Vontobel Holding’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,500
Closed -$55K – 1169
2024
Q4 		$55K Hold
2,500
– – ﹤0.01% 1068
2024
Q3 		$50.2K Hold
2,500
– – ﹤0.01% 1059
2024
Q2 		$43.5K Buy
2,500
+1,000
+67% +$32.7K ﹤0.01% 1048
2024
Q1 		$62.5K Hold
1,500
– – ﹤0.01% 1046
2023
Q4 		$37.7K Hold
1,500
– – ﹤0.01% 1078
2023
Q3 		$49K Hold
1,500
– – ﹤0.01% 1042
2023
Q2 		$87.3K Buy
+1,500
New +$77.1K ﹤0.01% 1056

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vontobel Holding's XFOR Position: Q1 2025 in Review

Vontobel Holding sold out of X4 Pharmaceuticals (XFOR) in Q1 2025, closing a stake of 2,500 shares — an estimated $55K sold.

Vontobel Holding first reported a position in XFOR in Q2 2023 and held it in 7 quarters. The position peaked at $87.3K in Q2 2023. 93 funds tracked by Wall St. Rank hold XFOR as of Q1 2025.

  • Vontobel Holding reported no remaining X4 Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 2,500 X4 Pharmaceuticals shares in Q1 2025, an estimated $55K.
  • Vontobel Holding first reported a position in X4 Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Vontobel Holding's X4 Pharmaceuticals position peaked at $87.3K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.